VOLPE, Gisella

VOLPE, Gisella  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.087 secondi).
Titolo Data di pubblicazione Autore(i) File
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis 2013 C Panuzzo; S Crivellaro; C Casnici; E Cibrario; F Crasto; R Lorenzatti; F Daraio; K Crotta; G Carrà; A Morotti; G saglio; G Volpe
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches 2007 VOLPE G; CIGNETTI A; PANUZZO C; KUKA M; VITAGGIO K; BRANCACCIO M; PERRONE G; RINALDI M; PRATO G; FAVA M; GEUNA M; PAUTASSO M; CASNICI C; SIGNORI E; TONON G; TARONE G; MARELLI O; FAZIO VM; SAGLIO G
Analysis of microsatellite instability in chronic lymphoproliferative disorders 1996 Volpe, G; Gamberi, B; Pastore, C; Roetto, A; Pautasso, M; Parvis, G; Camaschella, C; Mazza, U; Saglio, G; Gaidano, G
Imatinib resistance in CML 2009 Volpe G; Panuzzo C; Ulisciani S; Cilloni D.
Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice 2012 Casnici C; Volpe G; Crotta K; Lattuada D; Saglio G; Marelli O.
Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. 2015 Roggero S; Vullo S; Volpe G; Piga A; Albera C
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 2015 C. Panuzzo, G. Volpe, E. Cibrario Rocchietti, C. Casnici, K. Crotta, S. Crivellaro, G. Carrà, F. Daraio, R. Lorenzatti, D. Torti, A. Morotti,O. Marelli, G. Saglio
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 2015 Panuzzo, Cristina; Volpe, Gisella; Cibrario Rocchietti, Elisa; Casnici, Claudia; Crotta, Katia; Crivellaro, Sabrina; Carrà, Giovanna; Lorenzatti, Roberta; Peracino, Barbara; Torti, Davide; Morotti, Alessandro; Camacho-Leal, Maria Pilar; Defilippi, Paola; Marelli, Ornella; Saglio, Giuseppe
New perspectives for molecular targeted therapy in human leukemias 2002 G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice 2009 Casnici C; Volpe G; Lattuada D; Crotta K; Kuka M; Panuzzo C; Mastrotto C; Tonon G; Fazio VM; Saglio G; Marelli O.
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients 2002 CILLONI D; GOTTARDI E; DE MICHELI D; SERRA A; VOLPE G; MESSA F; REGE-CAMBRIN G; GUERRASIO A; DIVONA A; LO COCO F; G. SAGLIO
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia 2004 SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D.
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients 2017 Casnici, Claudia; Crotta, Katia; Volpe, Gisella; Panuzzo, Cristina; Lattuada, Donatella; Mesiano, Giulia; Saglio, Giuseppe; Marelli, Ornella
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy 2016 Gallo, Daniela; Nicoli, Paolo; Calabrese, Chiara; Gaidano, Valentina; Petiti, Jessica; Rosso, Valentina; Signorino, Elisabetta; Carturan, Sonia; Bot-Sartor, Giada; Volpe, Gisella; Frassoni, Francesco; Saglio, Giuseppe; Cilloni, Daniela